FIELD: biotechnology.
SUBSTANCE: invention is a method of determining the nonspecific resistance of pathogenic microorganisms to antibiotics and the fact of the presence of bacterial biofilms on the basis of measurement of catalytic activity of phosphodiesterases cleaving the cyclic diguanosine monophosphate, with a threshold sensitivity of 50 pg/ml, comprising: 1) isolating the target-phosphodiesterase from lysed bacterial cells; 2) binding of phosphodiesterase with biotin-conjugated antibodies specific for non-catalytic domains of phosphodiesterase; 3) affinity purification of complexes formed by target-phosphodiesterase and biotin-conjugated antibody using paramagnetic particles containing neutravidin or its analogs that bind biotin; 4) interacting of the complexes of phosphodiesterase/biotin-conjugated antibody, immobilised on paramagnetic particles with complexes containing a-di-GMP in the form of G-quadruplex systems with intercalate dye, which is accompanied by decrease in the intensity while destruction of complexes of intercalate dye with c-di-GMP; 5) measurement of decrease of fluorescence upon hydrolysis with c-di-GMP and destruction of complex of c-di-GMP with intercalate dye, followed by quantitative estimation of the phosphodiesterase activity based on calibration curves made using known amounts of the recombinant enzyme of phosphodiesterase identical to the test target; 6) identification of increased level of phosphodiesterase activity detected by the test antibiotic-resistant bacterial strains capable of biofilm formation, as compared with the level of phosphodiesterase activity that can be detected for the control strains of bacteria of the same species not having the antibiotic resistance and the ability to form biofilms.
EFFECT: method enables to determine the nonspecific resistance of pathogenic microorganisms to antibiotics and to establish the fact of the presence of bacterial biofilms.
4 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITIONS | 2018 |
|
RU2791256C2 |
METHOD OF PRODUCING BACTERIOPHAGE | 2015 |
|
RU2603730C1 |
METHOD FOR IDENTIFICATION OF NOSOCOMIAL OPPORTUNISTIC INFECTIONS PATHOGENS AND MARKERS OF THEIR RESISTANCE TO BETA-LACTAM ANTIBIOTICS AND GLYCOPEPTIDES IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR ANTIBACTERIAL THERAPY OPTIMISATION | 2016 |
|
RU2629322C1 |
PHOTOSTABLE PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF FOCI OF BACTERIAL DISEASE | 2017 |
|
RU2662082C2 |
METHOD OF DESTROYING AND PREVENTING FORMATION OF BACTERIAL BIOFILMS BY COMPLEX OF ANTIMICROBIAL PEPTIDES OF INSECTS | 2017 |
|
RU2664708C1 |
MEANS FOR SELECTIVE EFFECT ON BIOFILM FORMATION BY MICROORGANISMS | 2016 |
|
RU2646488C2 |
MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
DIGITAL MICROBIOLOGY | 2017 |
|
RU2772844C2 |
METHOD TO DETECT AVAILABILITY OF BACTERIA Escherichia coli O157:H7 IN BIOLOGICAL AND FOOD SAMPLES BASED ON IMMUNODETECTION COUPLED WITH POLYMERASE CHAIN REACTION | 2014 |
|
RU2569196C1 |
BACTERIOPHAGE LYTIC ENZYME AND ANTIBACTERIAL COMPOSITION BASED THEREON | 2018 |
|
RU2703043C1 |
Authors
Dates
2014-06-10—Published
2012-10-16—Filed